Holdings
Merck & Co., Inc.
As of Jun 30, 2026, Merck & Co., Inc. reported 12 positions worth US$523M. Largest: Personalis, Inc., Moderna, Inc. and Kymera Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Personalis, Inc. | 14M | US$188M | no change | Jun 30, 2026 |
| Moderna, Inc. | 2.31M | US$162M | no change | Jun 30, 2026 |
| Kymera Therapeutics, Inc. | 772K | US$88.5M | no change | Jun 30, 2026 |
| Aktis Oncology, Inc. | 953K | US$30.7M | no change | Jun 30, 2026 |
| Eikon Therapeutics, Inc. | 1.67M | US$21.7M | no change | Jun 30, 2026 |
| Entrada Therapeutics, Inc. | 1.74M | US$12.8M | new | Jun 30, 2026 |
| Sutro Biopharma, Inc. | 272K | US$9.04M | new | Jun 30, 2026 |
| Alector, Inc. | 3.55M | US$7.13M | no change | Jun 30, 2026 |
| Viridian Therapeutics, Inc. | 93,414 | US$1.72M | no change | Jun 30, 2026 |
| Xilio Therapeutics, Inc. | 106K | US$1.02M | no change | Jun 30, 2026 |